Momenzadeh Sirous, Abbasi Mohammadzaki, Ebadifar Asghar, Aryani Mohammadreza, Bayrami Jafar, Nematollahi Fatemeh
Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shohadaei Khalije Fars Hospital, Bushehr University of Medical Sciences, Boushehr, Iran.
J Lasers Med Sci. 2015 Winter;6(1):6-9.
Intravenous laser blood irradiation was first introduced into therapy by the Soviet scientists EN.Meschalkin and VS.Sergiewski in 1981. Originally this method was developed for the treatment of cardiovascular diseases. Improvement of rheologic properties of the blood as well as improvement of microcirculation and reduction of the area of infarction has been proved. Further, reduction of dysrhythmia and sudden cardiac death was achieved. At first, only the Helium-Neon laser (632.8 nm) was used in this therapy. For that, a power of 1-3mW and a period of exposure of 20-60 minutes were applied. The treatments were carried out once or twice a day up to ten appointments in all1. In the years after, many, and for the most part Russian studies showed that helium-neon laser had various effects on many organs and on the hematologic and immunologic system. The studies were published mainly in Russian which were little known in the West because of decades of political separation, and were regarded with disapproval. Besides clinical research and application for patients, the cell biological basis was developed by the Estonian cell biologist Tiina Karu at the same time. An abstract is to be found in her work "The Science of Low-Power Laser-Therapy"
1981年，苏联科学家E.N.梅沙尔金和V.S.谢尔吉耶夫斯基首次将静脉激光血液照射引入治疗领域。最初，这种方法是为治疗心血管疾病而开发的。现已证实，它能改善血液的流变学特性，改善微循环并缩小梗死面积。此外，还能减少心律失常和心源性猝死。起初，这种治疗仅使用氦氖激光（632.8纳米）。为此，采用1 - 3毫瓦的功率和20 - 60分钟的照射时间。治疗每天进行一次或两次，总共最多进行十次。在随后的几年里，许多（大部分是俄罗斯的）研究表明，氦氖激光对许多器官以及血液和免疫系统有多种影响。这些研究主要以俄语发表，由于数十年的政治隔离，在西方鲜为人知，且不被认可。除了针对患者的临床研究和应用外，爱沙尼亚细胞生物学家蒂娜·卡鲁同时也在开展细胞生物学基础研究。在她的著作《低功率激光治疗科学》中可以找到一篇摘要。
